1.Clinical Study on Acute Myocardial Infarction.
Si Yeul SEONG ; Min Chul KIM ; Hyung Jin KIM ; Dae Kyun SHIN ; Sung Hue PARK ; Ho Soo HAN ; Jong Jun KIM ; David B CHU
Korean Circulation Journal 1983;13(2):363-369
A retrospective clinical study was done on 78 cases of acute myocardial infarction admitted to Jeonje Presbyterian Medical Center from Jenuary 1972 to June 1982. The following results had been obtained. 1) The ratio of male to female patients with acute myocardial infarction was 3.9:1. Most patients were in the age group between the 6th and 7th decade(64%). 2) The number of patients admitted annually was about 8, and was increased 2.5 folds in the latter 5 years as compared with the first 5 years. 3) The most common past illnesses of patients with acute myocardial infarction were coronary insufficiency with angina pectoris, hypertension, previous myocardial infarction, diabetes mellitus, valvular heart disease and hyperthyroidism in order named. The patients without significant past illness amount to 41.0%. 4) Among the patients with acute myocardial infarction smokers were 1.9 times as many as non-smokers. 5) The chief complaints of the patients with acute myocardial infarction on admission were chest pain(60.3%), dyspnea(26.9%) and mental change(6.4%). 6) The distribution of the patients withacute myocardial infarction by Killip classification was as follows: Class I, 47.4%, class II, 16.7%, class III, 16.7% and class IV, 19.2%. 7) The most common location of acute myocardial infarction by EKG was anterior wall of the myocardium at 79.5%. 8) The patients with arrhythmia by EKG amount to 53.8% and conduction disturbance 20.5%. 9) The patients with acute myocardial infarction who expired during admission were 23%. The ratio of male to female was 2.6:1. Among the expired patients Killip class IV was 80.8% and anterior wall infarction was 77.8%.
Angina Pectoris
;
Arrhythmias, Cardiac
;
Classification
;
Diabetes Mellitus
;
Electrocardiography
;
Female
;
Heart Valve Diseases
;
Humans
;
Hypertension
;
Hyperthyroidism
;
Infarction
;
Male
;
Myocardial Infarction*
;
Myocardium
;
Protestantism
;
Retrospective Studies
;
Thorax
2.Total Knee Arthroplasty in Stiff Knee.
Woo Shin CHO ; Jong Hue PARK ; Jung Min KIM ; Se Kwan OH
Journal of the Korean Knee Society 2003;15(1):1-9
PURPOSE: To evaluate the results of TKRA (Total knee replacement arthroplasty)for the treatment of stiff knee. METHODS & MATERIALS: TKRA has been performed for 18 cases of stiff knee ( ROM < 50 degrees ) between January 1994 and December 2000. 16 cases which have been followed up for more than 2 years were analysed. Average follow-up was 3.3 years(2-6 years). 3 were male and 13 were female. The average age was 55.8 years(34-75years). Sequales of infection were most with 6 cases and followed by osteoarthritis (4 cases, 2 cases had been performed arthroscopic debridement) and rheumatoid arthritis (3 cases) and traumatic arthritis (3 cases) in order. TKRA was performed on average 12.2 years (1-40 years) after knee stiffness has been developed. We evaluate the results with ROM, HSS score and complications. RESULTS: Average ROM was increased from 31.6 degrees(0 degrees-50 degrees) preoperatively to 95.4 degrees(80 degrees-120 degrees) postoperatively. 5 degrees of flexion contracture was present in only 1 case. Average HSS score was improved from 59.6 points preoperatively to 84.6 points postoperatively. The patella tendon was partially ruptured in 1 case during surgery, but by brace application and rehabilitative exercise, ROM was improved to 90 degrees, 1 year post operatively. There were 1 superficial skin infection which was resolved by revision of wound and skin graft, and deep infection in 3 cases, which needed knee fusion finally. CONCLUSION: TKRA is a good method for improving function in knee stiffness although infection risk is high.
Arthritis
;
Arthritis, Rheumatoid
;
Arthroplasty*
;
Braces
;
Contracture
;
Female
;
Follow-Up Studies
;
Humans
;
Knee*
;
Male
;
Osteoarthritis
;
Patellar Ligament
;
Skin
;
Transplants
;
Wounds and Injuries
3.Evaluation of Mechanical Ventilation and Its Influencing Factors between the Living Related Liver Transplantation and Cadaveric Whole Liver Transplantation.
Jae Min LEE ; Hae Wone CHANG ; Chul Soo PARK ; Hue Jung PARK ; Jeong Eun KIM ; Jong Ho CHOI
Korean Journal of Anesthesiology 2005;49(6):816-821
BACKGROUND: Postoperative pulmonary complications are amongst the greatest causes of morbidity and mortality during liver transplantation. Postoperative mechanical ventilation and tracheal extubation are important parts of postoperative critical care. However, there are no comparative studies on postoperative mechanical ventilation, duration of intensive care units admission between cadaveric whole liver transplantation and living related liver transplantation groups, which are different from anesthetic and surgical procedures. In our present study, we have compared mechanical ventilation, duration of ICU admission and its influencing factors between the two groups. METHODS: We have retrospectively studied 67 cases and depending on the surgical procedures, we divided them into two groups; control group undergoing cadaveric whole liver transplantation and experimental group undergoing living related liver transplantation. Each group was evaluated based on operation time, time of mechanical ventilation, duration of ICU admission, amounts of infused fluid and transfusion during operation, preoperative and extubation O2 index, serum creatinine levels, and preoperative and intraoperative risk score. RESULTS: The mechanical ventilation time in experimental group was observed to be shorter than in control group, and serum creatinine level during the 3rd postoperative day in experimental group was lower than in control group (P<0.05). However, there was no difference in duration of ICU admission, O2 index, fluid amount and transfusion, and risk score between the two groups. CONCLUSIONS: We conclude that living related liver transplantation reduces mechanical ventilation time with no effect on ICU admission periods. Higher risk score is correlated with prolongation of postoperative mechanical ventilation.
Airway Extubation
;
Cadaver*
;
Creatinine
;
Critical Care
;
Intensive Care Units
;
Liver Transplantation*
;
Liver*
;
Mortality
;
Respiration, Artificial*
;
Retrospective Studies
4.Analgesic Effects of Dexmedetomidine in Vincristine-Evoked Painful Neuropathic Rats.
Hue Jung PARK ; Young Hoon KIM ; Hyun Jung KOH ; Chul Soo PARK ; Seung Hee KANG ; Jong Ho CHOI ; Dong Eon MOON
Journal of Korean Medical Science 2012;27(11):1411-1417
Dexmedetomidine, which is a selective alpha2-adrenoceptor agonist, was recently introduced into clinical practice for its analgesic properties. The purpose of this study was to evaluate the effects of dexmedetomidine in a vincristine-evoked neuropathic rat models. Sprague-Dawley rats were injected intraperitoneally with vincristine or saline (0.1 mg/kg/day) using a 5-day-on, 2-day-off schedule for 2 weeks. Saline and dexmedetomidine (12.5, 25, 50, and 100 microg/kg) were injected to rats developed allodynia 14 days after vincristine injection, respectively. We evaluated allodynia at before, 15, 30, 60, 90, 120, 180, and 240 min, and 24 hr after intraperitoneal drug (normal saline or dexmedetomidine) injection. Saline treatment did not show any differences for all the allodynia. Maximal paw withdrawal thresholds to mechanical stimuli were 3.0 +/- 0.4, 9.1 +/- 1.9, 13.0 +/- 3.6, 16.6 +/- 2.4, and 24.4 +/- 1.6 g at saline, 12.5, 25, 50, and 100 microg/kg dexmedetomidine injection, respectively. Minimal withdrawal frequency to cold stimuli were 73.3 +/- 4.2, 57.1 +/- 6.8, 34.3 +/- 5.7, 20.0 +/- 6.2, and 14.3 +/- 9.5 g at saline, 12.5, 25, 50, and 100 microg/kg dexmedetomidine injection, respectively. Dexmedetomidine shows a dose-dependent antiallodynic effect on mechanical and cold stimuli in vincristine-evoked neuropathic rat models (P < 0.05).
Analgesics/*therapeutic use
;
Animals
;
Behavior, Animal/drug effects
;
Dexmedetomidine/*therapeutic use
;
Disease Models, Animal
;
Hyperalgesia/chemically induced/*drug therapy
;
Injections, Intraperitoneal
;
Male
;
Pain Threshold
;
Rats
;
Rats, Sprague-Dawley
;
Vincristine/toxicity
5.Analgesic Effects of Dexmedetomidine in Vincristine-Evoked Painful Neuropathic Rats.
Hue Jung PARK ; Young Hoon KIM ; Hyun Jung KOH ; Chul Soo PARK ; Seung Hee KANG ; Jong Ho CHOI ; Dong Eon MOON
Journal of Korean Medical Science 2012;27(11):1411-1417
Dexmedetomidine, which is a selective alpha2-adrenoceptor agonist, was recently introduced into clinical practice for its analgesic properties. The purpose of this study was to evaluate the effects of dexmedetomidine in a vincristine-evoked neuropathic rat models. Sprague-Dawley rats were injected intraperitoneally with vincristine or saline (0.1 mg/kg/day) using a 5-day-on, 2-day-off schedule for 2 weeks. Saline and dexmedetomidine (12.5, 25, 50, and 100 microg/kg) were injected to rats developed allodynia 14 days after vincristine injection, respectively. We evaluated allodynia at before, 15, 30, 60, 90, 120, 180, and 240 min, and 24 hr after intraperitoneal drug (normal saline or dexmedetomidine) injection. Saline treatment did not show any differences for all the allodynia. Maximal paw withdrawal thresholds to mechanical stimuli were 3.0 +/- 0.4, 9.1 +/- 1.9, 13.0 +/- 3.6, 16.6 +/- 2.4, and 24.4 +/- 1.6 g at saline, 12.5, 25, 50, and 100 microg/kg dexmedetomidine injection, respectively. Minimal withdrawal frequency to cold stimuli were 73.3 +/- 4.2, 57.1 +/- 6.8, 34.3 +/- 5.7, 20.0 +/- 6.2, and 14.3 +/- 9.5 g at saline, 12.5, 25, 50, and 100 microg/kg dexmedetomidine injection, respectively. Dexmedetomidine shows a dose-dependent antiallodynic effect on mechanical and cold stimuli in vincristine-evoked neuropathic rat models (P < 0.05).
Analgesics/*therapeutic use
;
Animals
;
Behavior, Animal/drug effects
;
Dexmedetomidine/*therapeutic use
;
Disease Models, Animal
;
Hyperalgesia/chemically induced/*drug therapy
;
Injections, Intraperitoneal
;
Male
;
Pain Threshold
;
Rats
;
Rats, Sprague-Dawley
;
Vincristine/toxicity
6.Comparative Analysis of Therapeutic Effect between Topical Vancomycin and Systemic Vancomycin in Otorrhea by Methicillin-resistent Staphylococcus Aureus (MRSA) Infection.
Seung Hwan LEE ; Chul Won PARK ; Kyung TAE ; In Beom PARK ; Young Don HUE ; Jung Oak KANG ; Jong Woo KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 1999;42(6):704-708
BACKGROUND AND OBJECTIVES: Recently, methicillin resistent Staphylococcus aureus (MRSA) infecton in persistent otorrhea is on the increase. Beside the systemic side effects of vancomycin, systemic vancomycin injection needs admission and higher medical cost. We used vancomycin topically in the treatment of otorrhea by MRSA infection to minimize the disadvantages of systemic vancomycin injection. The objective of this study was to compare the therapeutic effects between topical and systemic use of vancomycin. MATERIALS AND METHODS: Twenty-five patients with persistent otorrhea were performed ordinary culture and sensitivity test. Among them, 18 patients were proved to have MRSA and they were divided into two groups. One group was treated with topical vancomycin packing, the other with systemic injection. RESULTS: MRSA was cultured in 18 cases (72%) among the 25 patients with persistent otorrhea. Therapeutic effects of topical vancomycin on MRSA infection was 77% and the average therapeutic period was 13.5 days. On the other hand, therapeutic effect was 100% and the average period was 5.6 days in systemic vancomycin injection group. CONCLUSION: Topical vancomycin packing in the treament of chronic otitis media with MRSA infection has advantages in view of time and economy, though the average therapeutic period is longer than that of systemic vancomycin injection.
Hand
;
Humans
;
Methicillin
;
Methicillin-Resistant Staphylococcus aureus
;
Otitis Media
;
Staphylococcus aureus*
;
Staphylococcus*
;
Vancomycin*
7.Follow-Up Study of 6-Month Short Course Chemotherapyfor Pulmonary Tuberculosis with 2SKHRZ/4HRZ.
Hyung Ki KOH ; Yun Jung KANG ; Seong Yong LIM ; Jong Wook SHIN ; Jae Sun CHOI ; Ji Hoon YOO ; In Won PARK ; Byoung Whui CHOI ; Sung Ho HUE ; Seung Chun SEO
Tuberculosis and Respiratory Diseases 1996;43(6):852-861
Background: Many clinicians have experienced the difficulty of decision on termination of antituberculosis chemotherapy after the 6th month due to relapse of disease. There is still controversy in the effect of 2S(K)HRZ/4HRZ 6-month short course chemotherapy including pyrazinamide for 6 months in patients with pulmonary tuberculosis. And there is no long term follow-up study of 6-month short course chemotherapy for pulmonary tuberculosis in korea. So we had performed the study to find the result of 6-month antituberculosis chemotherapy for 4 years. Method: We studied prospectively the effect of 2S(K)HRZ/4HRZ in one hundred-fifty patients with pulmonary tuberculosis and followed up fifty-nine patients for more than 1 year to 4 years after the completion of 6-month short course therapy. Results: 1) Out of one hundred-fifty patients, seventy-two patients(48%) completed the prescribed 6-month chemotherapy. Sixty-eight patients(45.3%) have experienced premature discontinuation and the most common cause of premature discontinuation was drop-out against advice(thirty-six patients, 24%). Ten patients(6.7%) were treated beyond the 6 months mainly due to irregular treatment. 2) Fifty-nine patients(81.9%) among seventy-two patients with completed treatment have been followed up for more than 1 year and 32 patients(44.4%) for more than 4 years. There was three relapse patients of whom two patients have experienced relapse of pulmonary tuberculosis within 1 year after the termination of chemotherapy. 3) Among one hundred-thirty-four patients who have been assessible for more than two months of chemotherapy, including the patients who experienced within 2 months, there were eighty-two patients(61.2%) who have experienced adverse reactions and the treament regimen was changed only in thirteen patients(9.7%). The most frequent cause of adverse reactions was arthralgia and/or hyperuricemia, which had occurred in 33 patients(24.6%). Conclusion: In a university hospital in Korea, 6-month short course chemotherapy of 2S(K)HRZ/4HRZ had unnegligible relapses and premature discontinuation. Therefore, change of the regimen might be carefully considered by drug susceptibility results. Close monitoring of patients, retrial of sputum exam and radiologic evaluation during treatment might be required in the endemic area of drug resistant strains like in Korea. Further study about the effect of 6-month short course chemotherapy including pyrazinamide for 6-month might be needed.
Arthralgia
;
Drug Therapy
;
Follow-Up Studies*
;
Humans
;
Hyperuricemia
;
Korea
;
Prospective Studies
;
Pyrazinamide
;
Recurrence
;
Sputum
;
Tuberculosis, Pulmonary*
8.Factors of bronchial hyperresponsiveness in patients with chronic airflow obstruction.
Byoung Whui CHOI ; In Won PARK ; Jae Sun CHOI ; Jong Wook SHIN ; Seong Yong LIM ; Moon Jun NA ; Sung Ho HUE ; Byoung Hoon LEE ; Chang Hyeok AN ; Ji Hoon YOO ; Kwang Seok KIM
Korean Journal of Allergy 1997;17(3):250-259
To evaluate the effect of allergic parameters, such as serum IgE, eosinophil, and skin test on the bronchial hyperresponsiveness (BHR) in patients with chronic airflow obstruction, we performed methacholine bronchial provocation test, pulmonary function test, skin prick test, and measured blood eosinophil counts and serum IgE level from seventy-nine patients who showed persistent fixed airflow obstruction, less than 75% of predicted value in FEV~ and FEV1/FVC, despite of conventional treatment without steroid therapy for more than 3 months. The results were as follows 1) There were 53 patients with BHR and 26 patients without BHR. There were no statistically significant differences in sex, age, and smoking duration between positive BHR group and negative BHR group (p>0.05). 2) There was no statistically significant difference in absolute and predicted value of FVC(p>0.05). But there were significantly lower absolute, predicted value of FEV1 and FEV1/FVC% in positive group compared with negative group (p<0.05). 3) There was somewhat higher trend of serum IgE level in positive group. Skin test was not significantly different between two groups (p > 0.05 ). 4) Blood eosinophil count was significantly higher in positive group than in negative group(p<0.05). Conclusion of this study is that increased bronchial responsiveness in patients with chronic airflow obstruction is inversely related to the level of pulmonary function and significantly associated with blood eosinophilia.
Bronchial Provocation Tests
;
Eosinophilia
;
Eosinophils
;
Humans
;
Immunoglobulin E
;
Methacholine Chloride
;
Pulmonary Disease, Chronic Obstructive*
;
Respiratory Function Tests
;
Skin
;
Skin Tests
;
Smoke
;
Smoking
9.Predictors of drug-resistance in patients with pulmonary tuberculosis.
Hyung Ki KOH ; Yoon Jung KANG ; Sung Yong LIM ; Jong Wook SHIN ; Jae Sun CHOI ; Ji Hoon YOO ; Jae Yeol KIM ; In Won PARK ; Byoung Whui CHOI ; Sung Ho HUE
Tuberculosis and Respiratory Diseases 1999;46(3):311-316
BACKGROUND: The drug-resistant tuberculosis has recently decreased in Korea, but it is still one of the major obstacles in the treatment of pulmonary tuberculosis. Unfortunately there are no reliable ways to figure out the drug sensitivity pattern of the M. tuberculosis in the starting point of treatment. At least several months which is critical for the success of treatment have to be passed away before getting the report of drug-sensitivity test. The aim of this study was to find out the clinical and radiological parameters that make it possible to predict the drug-resistant pulmonary tuberculosis and to make a correct decision on the antituberculosis drug regimens. METHOD: We studied 253 pulmonary TB patients with sputum and/or bronchial washing fluid culture-positive diagnosed at the Chung-Ang University Young-San Hospital in the period of 1989-1994. The differences in the clinical and raiological variables between the drug-sensitive and the drug-resistant tuberculosis patients were evaluated. RESULTS: In 66 out of 253 patients(26.1%), drug resistant tuberculosis to at least one antituberculosis drug were found. Patients with retreatment showed higher resistance rate than those with initial treatment (30/69,43.5% vs 36/184, 19.5%, p<0.01). Patients with cavitary TB showed higher resistance rate than those with non-cavitary TB( (24/54, 44.4% vs 42/199, 21.1%, p<0.05). Among patients with initial treatment, those with far-advanced TB showed a higher drug resistance rate than those with minimal lesion(9/23, 36.9% vs 10/82, 12.5%, p<0.05). Patients with culture positive only in the bronchial washing fluid showed lower resistance rate than those with sputum culture positive(7/63, 11.1% vs 59/190, 31.1%, p<0.05) CONCLUSION: Prior treatment history for pulmonary tuberculosis, the presence of cavity & far advanced tuberculosis in the radiologic exam, sputum rather than solely bronchial washing culture positivity would be the related factors to the drug resistance. So in the patients with such characteristics, it is needed to try to find out the drug sensitivity pattern of the infecting tuberculosis organism as soon as possible.
Drug Resistance
;
Humans
;
Korea
;
Retreatment
;
Sputum
;
Tuberculosis
;
Tuberculosis, Multidrug-Resistant
;
Tuberculosis, Pulmonary*
10.The Effects of Baicalein on Osteoclast Differentiation from Bone Marrow Derived Macrophage.
Ji Kwang YUN ; Yoon Hee CHEON ; Ju Young KIM ; Seong Cheoul KWAK ; Kang Hue YOON ; Jong Min BAEK ; Myeong Su LEE ; Jaemin OH ; Jongtae PARK
Korean Journal of Physical Anthropology 2014;27(2):91-99
As prediction of rapidly aging society, bone health is considered increasingly important and received more attention than ever. Bone health is regulated by balancing between bone resorptive osteoclasts and bone formative osteoblasts. Disruption of balance between bone-resorbing osteoclasts and bone-forming osteoblasts results in bone disease. Natural products have recently received much attention as an alternative tool for the development of novel therapeutic strategy. Baicalein is reported it has anti-cancer, anti-inflammatory and antioxidant effects. Baicalein also has been known that it has both promotive effect on MC3T3-E1 cell line and inhibitory effect on RAW 264.7 cell line. However, the inhibitory mechanism of baicalein using bone marrow derived macrophages (BMMs) on osteoclast differentiation remains not clear. In this study, the suppressive mechanism by baicalein on osteoblast differentiation was evaluated. Bicalein inhibited receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast differentiation in BMMs in a dose dependent manner without any toxicity. Baicalein suppressed phosphorylation of protein kinaseB (Akt), c-Jun N-terminal kinases (JNK) and phosphoinositide-specific phospholipaseCgamma2 (PLCgamma2). Furthermore, Baicalein suppressed the induction of RANKL-induced c-Fos and Nuclear factor of activated T cell c1 (NFATc1), essential genes on osteoclastogenesis. In BMMs, Bicalein inhibited the mRNA expression of tartrate-resistant acid phosphatase (TRAP), osteoclast-associated receptor (OSCAR), cathepsinK, dendritic cell-specific transmembrane protein (DC-STAMP). Moreover, baicalein promoted differentiation of osteoblast on bone marrow stromal cells (BMSCs). Taken together, these results suggest that baicalein has a potential for treating bone lytic diseases, such as osteoporosis, periodontitis, and rheumatoid arthritis.
Acid Phosphatase
;
Aging
;
Antioxidants
;
Arthritis, Rheumatoid
;
Biological Products
;
Bone Diseases
;
Bone Marrow*
;
Cell Line
;
Genes, Essential
;
Macrophages*
;
Mesenchymal Stromal Cells
;
Osteoblasts
;
Osteoclasts*
;
Osteoporosis
;
Periodontitis
;
Phospholipase C gamma
;
Phosphorylation
;
Phosphotransferases
;
RANK Ligand
;
RNA, Messenger